BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35162973)

  • 1.
    Grandits AM; Bromberger S; Heller G; Reinoehl BA; Tomasich E; Schossleitner K; Berghoff AS; Fuereder T; Wieser R
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EVI1 as a Marker for Lymph Node Metastasis in HNSCC.
    Idel C; Ribbat-Idel J; Kuppler P; Krupar R; Offermann A; Vogel W; Rades D; Kirfel J; Wollenberg B; Perner S
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/β-catenin signaling axis.
    Lee K; Chang JW; Oh C; Liu L; Jung SN; Won HR; Kim YI; Rha KS; Koo BS
    Eur J Surg Oncol; 2020 Jun; 46(6):1066-1073. PubMed ID: 31864826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC.
    Li J; Yan T; Wu X; Ke X; Li X; Zhu Y; Yang J; Li Z
    BMC Cancer; 2021 Nov; 21(1):1205. PubMed ID: 34772357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine promotes lymph node metastasis and cetuximab resistance in head and neck squamous cell carcinoma.
    Shimizu R; Ibaragi S; Eguchi T; Kuwajima D; Kodama S; Nishioka T; Okui T; Obata K; Takabatake K; Kawai H; Ono K; Okamoto K; Nagatsuka H; Sasaki A
    Int J Oncol; 2019 Jan; 54(1):283-294. PubMed ID: 30431077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Study on the Correlations of the miR-31 Expression with the Pathogenesis and Prognosis of Head and Neck Squamous Cell Carcinoma.
    Qiang H; Zhan X; Wang W; Cheng Z; Ma S; Jiang C
    Cancer Biother Radiopharm; 2019 Apr; 34(3):189-195. PubMed ID: 30628842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
    Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma.
    Chi LH; Chang WM; Chang YC; Chan YC; Tai CC; Leung KW; Chen CL; Wu AT; Lai TC; Li YJ; Hsiao M
    Sci Rep; 2017 Aug; 7(1):9031. PubMed ID: 28831179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulated miR‑20a‑5p expression promotes proliferation and invasion of head and neck squamous cell carcinoma cells by targeting of TNFRSF21.
    Wu H; Pang P; Liu MD; Wang S; Jin S; Liu FY; Sun CF
    Oncol Rep; 2018 Aug; 40(2):1138-1146. PubMed ID: 29901115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LASP1 promotes proliferation, metastasis, invasion in head and neck squamous cell carcinoma and through direct interaction with HSPA1A.
    Chen Q; Wu K; Qin X; Yu Y; Wang X; Wei K
    J Cell Mol Med; 2020 Jan; 24(2):1626-1639. PubMed ID: 31793711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of TP63 Promotes the Metastasis of Head and Neck Squamous Cell Carcinoma by Activating MAPK and STAT3 Signaling.
    Lakshmanachetty S; Balaiya V; High WA; Koster MI
    Mol Cancer Res; 2019 Jun; 17(6):1279-1293. PubMed ID: 30910837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
    Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
    Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAM83A promotes proliferation and metastasis via Wnt/β-catenin signaling in head neck squamous cell carcinoma.
    Ji H; Song H; Wang Z; Jiao P; Xu J; Li X; Du H; Wu H; Zhong Y
    J Transl Med; 2021 Oct; 19(1):423. PubMed ID: 34641907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non‑coding RNA MIR4435‑2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR‑383‑5p/RBM3 axis.
    Wang S; Chen X; Qiao T
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
    Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SUZ12 is a novel putative oncogene promoting tumorigenesis in head and neck squamous cell carcinoma.
    Wu Y; Hu H; Zhang W; Li Z; Diao P; Wang D; Zhang W; Wang Y; Yang J; Cheng J
    J Cell Mol Med; 2018 Jul; 22(7):3582-3594. PubMed ID: 29667751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus.
    Jiang Y; Cao W; Wu K; Qin X; Wang X; Li Y; Yu B; Zhang Z; Wang X; Yan M; Xu Q; Zhang J; Chen W
    J Exp Clin Cancer Res; 2019 Aug; 38(1):365. PubMed ID: 31429766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation.
    Chang JW; Jung SN; Kim JH; Shim GA; Park HS; Liu L; Kim JM; Park J; Koo BS
    Sci Rep; 2016 Jun; 6():28503. PubMed ID: 27328758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-expression network-based identification of biomarkers correlated with the lymph node metastasis of patients with head and neck squamous cell carcinoma.
    Jin Y; Qin X
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32076707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
    Qi CL; Sheng JF; Huang ML; Zou Y; Wang YP; Wang F; Zeng F; Hua QQ; Chen SM
    Medicine (Baltimore); 2021 Feb; 100(6):e24618. PubMed ID: 33578572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.